← All trials
NCT04824053
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2021
- Primary completion
- Dec 30, 2023
- Completion date
- Dec 15, 2024
- First posted
- Apr 1, 2021
- Last posted
- Jul 13, 2021
- Enrollment
- 34
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Instituto de Investigación Sanitaria AragónLead sponsor
- Instituto de Investigación Sanitaria AragónReponsible party - principal investigator
- Hospital Clinico Lozano BlesaCollaborator
- University of ZaragozaOverall official - principal investigator
- FEIRACO LACTEOS SLCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.